MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, S. G.
Right arrow Articles by Yoo, S. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, S. G.
Right arrow Articles by Yoo, S. Y.

0026-895X/97/020225-09$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 51:225-233 (1997).

Enhancement of Radiation-Inducible Hepatic Glutathione-S-Transferases Ya, Yb1, Yb2, Yc1, and Yc2 Gene Expression by Oltipraz: Possible Role in Radioprotection

Sang Geon Kim, Seon Young Nam, Choon Won Kim, Jeong Hee Kim, Chul Koo Cho, and Seong Yul Yoo

College of Pharmacy, Duksung Women's University (S.G.K., S.Y.N.), Department of Clinical Pathology, Hanyang University Medical School (C.W.K.), and Laboratory of Radiation Effect, Korea Cancer Center Hospital, Korea Atomic Energy Research Institute, Seoul, Korea (J.H.K., C.K.C., S.Y.R.)

Previous studies have shown that radiation in combination with oltipraz enhances hepatic microsomal epoxide hydrolase expression. The effects of gamma -ray radiation exposure in combination with oltipraz on the expression of hepatic glutathione-S-transferase (GST) subunits Ya, Yb1, Yb2, Yc1, and Yc2 were examined in the rat. Northern RNA blot analyses revealed that GST mRNA levels were altered in response to daily 3- or 0.5-Gy doses of radiation. The hepatic GST mRNA levels were transiently decreased at 3 and 8 hr after a single 3-Gy dose of radiation. The GST Ya, Yb1, Yb2, Yc1, and Yc2 mRNA levels were increased by 2-4-fold at 15 and 24 hr after irradiation with 3 Gy, followed by return to the levels of untreated rats at 48 hr after treatment. The treatment of animals with oltipraz alone resulted in dose-related increases in the GST Ya, Yb1, Yc1, and Yc2 mRNA levels, whereas Yb2 mRNA levels were minimally increased. Although a single dose of oltipraz (30 mg/kg orally) caused a minimal 2-fold elevation in the hepatic GST Ya mRNA level, exposure of animals to both oltipraz and 3-Gy radiation resulted in a 4-fold relative increase in GST Ya mRNA level, indicating that the Ya mRNA expression was additively enhanced by the combination treatment. The Yb1/2 and Yc1/2 mRNA expressions were also enhanced by oltipraz in combination with radiation. Multiple exposure of rats to daily 0.5-Gy radiation caused time-related increases in GST gene expression. The greatest enhancement in GST expression was observed at 24 hr after a single 0.5-Gy dose of radiation in conjunction with oltipraz (e.g., a 9-fold relative increase in GST Ya), whereas the relative additive increases in GST mRNA were less pronounced at day 3 or 5 after treatment. These increases in the GST mRNA levels were consistent with those in the immunochemically detectable GST protein levels. Histopathological examinations revealed that exposure of rats to radiation (0.5 Gy/day for 3-5 days) caused mild-to-moderate hepatocyte degeneration with sinusoidal congestion, whereas oltipraz (30 mg/kg/day for 3 days) was effective in blocking the radiation-induced liver injury. The enhanced expression of these GST isoforms by oltipraz may be associated in part with its hepatoprotective effect against the injury caused by ionizing radiation.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. W. Kim, H. E. Kang, M. G. Lee, S. J. Hwang, S. C. Kim, C. H. Lee, and S. G. Kim
Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes
Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G372 - G381.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Y. Lee, C. Y. Han, J. W. Yang, C. Smith, S. K. Kim, E. Y.-H. P. Lee, S. G. Kim, and K. W. Kang
Induction of Glutathione Transferase in Insulin-Like Growth Factor Type I Receptor-Overexpressed Hepatoma Cells
Mol. Pharmacol., October 1, 2007; 72(4): 1082 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
I-N. Park, I. J. Cho, and S. G. Kim
Ceramide Negatively Regulates Glutathione S-transferase Gene Transactivation via Repression of Hepatic Nuclear Factor-1 That Is Degraded by the Ubiquitin Proteasome System
Mol. Pharmacol., June 1, 2004; 65(6): 1475 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Y. Park, I. J. Cho, and S. G. Kim
Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S-Transferase Gene by the Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Heterodimer
Cancer Res., May 15, 2004; 64(10): 3701 - 3713.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Zsivkovits, K. Fekadu, G. Sontag, U. Nabinger, W. W. Huber, M. Kundi, A. Chakraborty, H. Foissy, and S. Knasmuller
Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains
Carcinogenesis, December 1, 2003; 24(12): 1913 - 1918.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. W. Kang, S. Y. Choi, M. K. Cho, C. H. Lee, and S. G. Kim
Thrombin Induces Nitric-oxide Synthase via Galpha 12/13-coupled Protein Kinase C-dependent I-kappa Balpha Phosphorylation and JNK-mediated I-kappa Balpha Degradation
J. Biol. Chem., May 2, 2003; 278(19): 17368 - 17378.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. W. Kang, E. Y. Park, and S. G. Kim
Activation of CCAAT/enhancer-binding protein {beta} by 2'-amino-3'-methoxyflavone (PD98059) leads to the induction of glutathione S-transferase A2
Carcinogenesis, March 1, 2003; 24(3): 475 - 482.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. W. Kang, I. J. Cho, C. H. Lee, and S. G. Kim
Essential Role of Phosphatidylinositol 3-Kinase-Dependent CCAAT/Enhancer Binding Protein {beta} Activation in the Induction of Glutathione S-Transferase by Oltipraz
J Natl Cancer Inst, January 1, 2003; 95(1): 53 - 66.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. W. Kang, S. J. Lee, J. W. Park, and S. G. Kim
Phosphatidylinositol 3-Kinase Regulates Nuclear Translocation of NF-E2-Related Factor 2 through Actin Rearrangement in Response to Oxidative Stress
Mol. Pharmacol., November 1, 2002; 62(5): 1001 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. W. Kang, M. K. Cho, C. H. Lee, and S. G. Kim
Activation of Phosphatidylinositol 3-Kinase and Akt by tert-Butylhydroquinone Is Responsible for Antioxidant Response Element-Mediated rGSTA2 Induction in H4IIE Cells
Mol. Pharmacol., April 16, 2001; 59(5): 1147 - 1156.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
K. W. Kang, J. H. Ryu, and S. G. Kim
The Essential Role of Phosphatidylinositol 3-Kinase and of p38 Mitogen-Activated Protein Kinase Activation in the Antioxidant Response Element-Mediated rGSTA2 Induction by Decreased Glutathione in H4IIE Hepatoma Cells
Mol. Pharmacol., November 1, 2000; 58(5): 1017 - 1025.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
S. G. Kim, M. K. Cho, S. H. Choi, H. J. Kim, M. K. Kwak, and N. D. Kim
Molecular Basis for Hepatic Detoxifying Enzyme Induction by 2-(Allylthio)pyrazine in Rats in Comparison with Oltipraz: Effects on Prooxidant Production and DNA Degradation
Drug Metab. Dispos., June 1, 1999; 27(6): 667 - 673.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
S. G. Kim, J. Y. Cho, Y. S. Chung, E-T. Ahn, K.-Y. Lee, and Y.-B. Han
Suppression of Xenobiotic-Metabolizing Enzyme Expression in Rats by Acriflavine, a Protein Kinase C Inhibitor. Effects on Epoxide Hydrolase, Glutathione S-Transferases, and Cytochromes P450
Drug Metab. Dispos., January 1, 1998; 26(1): 66 - 72.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics